2009 Tour of California - Stage 8 Team Comments
Parting Shots - Team & Rider Comments: Fränk Schleck, Levi Leipheimer, Rory
Sutherland, Mike Tamayo of OUCH, and Alex Sans Vega of Cervelo TestTeam...
“I love racing in America. You see the crowds
here; they were amazing. To win two stages in the Amgen Tour of California
is quite special. We had a great time, not only racing, but on the team bus.
It was enjoyable and we were all excited to be here.” Mark Cavendish
Columbia/Highroad
Saxo Bank
Fantastic Victory for Fränk Schleck
Fränk Schleck and Team Saxo Bank closed this year's edition of Amgen Tour of
California with an impressive victory in the queen stage in the San Diego area.
The team launched a major attack early on in the mountainous stage from
Rancho Bernardo to Escondido and from here on Fränk Schleck controlled events
towards the finish line. After several attempts Liquigas' Vicenzo Nibali was the
only one able to hang on and in spite of a fiercely chasing Astana crew the duo
made it all the way.
Schleck sprinted his way to victory and concluded a successful week for Team
Saxo Bank with a victory in the prologue for Cancellara and the mountain jersey
for Jason McCartney. Jens Voigt finished best overall for the team in fourth
place.
”I was extremely motivated today and this type of stage made it possible for
me to go all the way. It was a great day for the team where we took a risk and
it's fantastic to see our tactics pan out this way. I was worn at the end but
luckily so was Nibali so I made it. It's still early in the season so I'm happy
to get this victory already and hopefully I'll be able to maintain my form for
the classics,” said a happy Fränk Schleck
after the stage.
”It's been a fantastic week for us. First the prologue victory and generally
during the week we've made our mark every single day. To be able to finish with
such a great win for Fränk is the perfect outcome. Amgen Tour of California has
grown into an important race and with this year's peloton this is a major
achievement by Fränk. He was out there in the break all day and still managed to
finish the job in the end, which takes guts and form,” said sports director
Bradley McGee after the victory.
Frank Schleck (LUX), Saxo Bank Winner, Stage 8
On today’s race:
“Three days ago, the plan was to just to keep our energy early and just go for
the last stage. Yesterday, I was in the break, but it was a very technical race
and I was a bit disappointed. The riding was furious today and I said I’m just
going to go for it again. The whole Saxo Bank team did a great job; the way we
played it was great. I was really impressed with my brother (Andy Schleck) and
Jason (McCartney) who have done really, really hard jobs the whole week. We put
them out there and then I attacked from behind and we caught up. Without those
guys, it never would have worked out.”
“On Palomar, that is where I attacked and got up to Andy, and then he set a
really hard pace. I wanted him to slow down (laughing). But, I stayed with him
and when we got to the last climb, that is when Nibali (Vincenzo) sped up and
then I just had to keep going very hard to hold on. Really, for a guy like me,
it took a big effort for me today for sure. I’m looking forward to having some
wine tonight.”
Levi Leipheimer, Astana
Three time Champion of the Amgen Tour of California
On winning for the third time in a row:
“I’ve been trying to think about how to articulate this and it’s
tough. To win it once, that was huge. To win it twice, that was almost a little
bit of a surprise and almost felt like luck. But now, to have won the Amgen Tour
of California three times, it’s the sweetest victory of all. It’s hard to
describe, but to keep a streak like that going is difficult. I told Lance
(Armstrong) that I don’t know how he won the Tour de France seven times in a
row, because the pressure builds with each win. The expectations are higher. I
think we proved that we were the best team in the race. There is no question
about that.”
On Mt. Palomar:
“With the speed that we went up Palomar, and the riders that we were surrounded
with, especially in the last kilometer, I had to remind myself that it was
February in California because it felt like the Alps in July. Like Lance said,
it (Mt. Palomar) is legit.”
On the crowds at the 2009 Amgen Tour of California overall:
“The Rose Bowl yesterday was unbelievable. It felt like Woodstock. No, actually,
it was bigger than Woodstock. Coming through the circuit laps, it was like
riding through a tunnel of noise; I couldn’t even hear Johan (team director).
The crowds everywhere were amazing. In my hometown of Santa Rosa, the conditions
were horrendous and I felt bad to see thousands of people suffering in the rain,
and I knew we couldn’t let them down. It’s just this awesome environment in
which to race. The riders feed off of it and race harder and more aggressively;
everyone comes with their ‘A’ game. The crowds really motivate us a lot.”
On becoming a team leader:
“It has been a long, hard learning process to become the best that I can be and
become a team leader. When the Amgen Tour of California came about in 2006, I
knew I had evolved into a rider that could win this race. I have always been
motivated for this race. This year, it was awesome because the team was so
strong that we didn’t even need a lot of direction. Everyone is so experienced
that we all know what each other are thinking. The riders can see each other and
know when to take it easy or when we need to go. It has been a long, hard road
to get to this point.
I’ve trained really hard and when I was pushing myself and suffering, I
dreamt of moments like the climb on Bonny Doon where it’s a long way to the
finish, the conditions are horrendous, but at the spur of the moment, you feel
inspired and great and you just go for it. You know that you’re fully committed
to pulling it off and grabbing the yellow jersey, and to have Lance working for
you the entire way, it’s like a life-long dream for me.”
Team OUCH/Maxxis
Sutherland takes 4th in Final Stage
Landis launches attacks on “home” turf.
Rory Sutherland of the OUCH Pro Cycling Team Presented by Maxxis narrowly missed
out on a podium spot in Stage 8 of the Amgen Tour of California in Escondido
Sunday. The Australian came 4th on the stage, finishing the width of a wheel
behind George Hincapie (Columbia-Highroad), his nemesis from the stage into
Pasadena in the 2008 edition of the race.
“George and I seem to have gone against each other a bit lately,”
Sutherland. “We talked a bit after the stage.
We always keep an eye on each other in groups like this because it’s the type of
group that we can win a sprint from. But I think he’s just a bit more of a pure
sprinter than I am.”
The sprint for 3rd on the stage, 0:39 after stage winner Frank Schleck (Saxo
Bank) and Vincenzo Nibali (Liquigas) had crossed the line, was not part of the
plan for today, noted OUCH P/by Maxxis team directeur sportif
Mike Tamayo. Instead, the intent was to launch
Floyd Landis on his home turf in the San Diego area.
“We set it up last night,”Tamayo said. “We wanted to be aggressive and go for
the stage win, or blow up trying.”
So heading up the second climb going over the Category 3 Lake Wohlford Road,
the team lined it up on the front and strung out, and then split the peloton.
Karl (Menzies) went first, then Brad (White), TJ (Tim Johnson) and Cam (Evans),”
Tamayo said. “Floyd got a gap and we broke up the field, but Astana had too much
horsepower. But we did get them to burn a match or two.”
Landis attacked again on Palomar Mountain, one of his favorite climbs for
training, but he still was unable to get away. On the descent, a group of 30
riders came together, including the race leaders, as well as Landis and
Sutherland.
“When we came into town, we played the card we had for the finish,” Tamayo
said.
That card turned out to be the unlikely site of Landis leading out Sutherland
into the final left-hand turn onto Grand Avenue for the run to the line. When
Landis dropped off Sutherland going into the final turn, the Australian came out
with Hincapie glued to his wheel. In the final 50 meters, the Hincapie was able
to just come around and pip Sutherland on the line.
“It would’ve been great to get 3rd today, but I’m happy with the result,”
Sutherland said. “It’s a bit frustrating to ride so aggressively all week, with
all of us getting in breaks just about every day, and not get the result we were
after.
“This race seems to get more difficult every year,” Sutherland continued. “It
was certainly much harder than last year. The weather didn’t help the first part
of the week, but if you look at the quality of the field, it’s just incredible.
Even BMC, which is a Continental Pro team and brought a quality squad, couldn’t
really get anything going. It just demonstrates how big this race has gotten in
such a short amount of time.”
Cervelo TestTeam
The final and toughest stage of the Tour of California finished today in
Escondido, 30 miles northeast of San Diego. The stages highlight was the climb
and descent of the 1.561 km summit of Mt. Palomar, which is above
categorization. It was a quiet day for the Cervélo TestTeam, though Serge Pauwel
was involved in the early stage of the breakaway that finally finished with two
riders Frank Schleck (SAX) who won the stage and Vincenzo Nibali (LIQ).
Alex Sans Vega commented after the race,
"It was a fast race today and Saxo Bank, Garmin-Slipstream and Liquigas pushed
the pace to make it even faster. Serge Pauwels was able to open a 2 minute gap
but when he hit Palomar they finally were able to pull him back. Íñigo Cuesta
has been sick for the last two days and put in an amazing effort being the only
TestTeam rider to stay with the front of the peloton to the end of the race."
Amgen Tour of California - Stage 8 Press Release
Defending Champion Levi Leipheimer Wins Third Consecutive Title
Two Million Fans Turned Out to Watch the Best Field Ever Assembled on U.S. Soil
Cycle Across California
After nine challenging and epic days of cycling through more than 750-miles of
scenic California roads, and a thrilling fight to the finish, Levi Leipheimer
(USA) of Astana was crowned champion of the 2009 Amgen Tour of California,
solidifying a three-peat for the California resident. With a week-long total
time of 31 hours, 28 minutes and 21 seconds, Leipheimer accepted the highly
coveted title of race champion in front of massive cheering crowds in Escondido,
which brought the race total to 2 million fans along the race route from
Sacramento to Escondido. In a nine-day battle against the best field ever
assembled to compete in the United States, which included Tour de France
winners, Olympic medalists and World Champions, Frank Schleck (LUX) of Saxo Bank
claimed the Stage 8 win.
“I’ve been trying to think about how to articulate this and it’s tough,” said
Leipheimer. “To win it once, that was huge. To win it twice, that was almost a
little bit of a surprise and almost felt like luck. But now, to have won the
Amgen Tour of California three times, it’s the sweetest victory of all. I think
we proved that we were the best team in the race. There is no question about
that.”
David Zabriskie (USA) of Garmin-Slipstream finished in second place overall
at 36 seconds behind Leipheimer, and Michael Rogers (AUS) of Team
Columbia-Highroad finished third at 45 seconds behind.
In one of the most difficult stages of the 2009 race, the 96.8-mile route
from Rancho Bernardo to Escondido included one sprint and four King of the
Mountain (KOM) climbs, including the ‘above categorization’ ascent of Palomar
Mountain, the highest point ever reached in the Amgen Tour of California at
5,123 feet. The ascent unfolded over 11.7 miles and included 21 switchbacks at
an average gradient of seven percent.
The Queen stage of the 2009 Amgen Tour of California began with an early
breakaway of nine riders, which was split up a half hour later. Soon after, a
second breakaway formed, which included Schleck and inaugural Amgen Tour of
California winner Floyd Landis (USA) of Ouch Presented by Maxxis. Chased and
eventually caught by the top-three riders in the general classification,
Leipheimer, Rogers and Zabriskie, the breakaway included most of the top riders
in the peloton.
Lined with fans, some of which had camped out for two nights to secure their
spot to watch the cyclists compete in the final day of the race, Mount Palomar
made the final stage of the race an extremely challenging course. Schleck opened
up a gap on the descent, but was then joined by three additional riders to make
a group of four. With Lance Armstrong (USA) of Astana setting a fast pace at the
front of the field, the gap began to close. After riding in the breakaway for
most of the day, Schleck battled Vincenzo Nibali (ITA) of Liquigas up to the
finish line to take the final stage with the roar of cheering fans in Escondido
in the background.
“The riding was furious today and I said, ‘I’m just going to go for it
again’,” said Schleck. “On Palomar, that is where I attacked and got up to Andy
(Schleck), and then he set a really hard pace. Really, for a guy like me, it
took a big effort today for sure.”
Today’s stage brought a close to the competition for the Amgen Tour of
California jerseys. The Amgen Leader Jersey was awarded to Leipheimer for the
third consecutive year. In addition to winning the final stage of the race,
Schleck claimed Amgen’s Breakaway from Cancer™ Most Courageous Rider Jersey.
Mark Cavendish (GBR) of Team Columbia-Highroad retained the Herbalife Sprint
Jersey and Rabobank’s Robert Gesink (NED) the Rabobank Best Young Rider Jersey.
Jason McCartney (USA) of Saxo Bank held onto the climbing lead to take the
California Travel & Tourism Commission King of the Mountain (KOM) Jersey. With a
celebratory champagne fight on the awards stage, Astana claimed the overall team
classification for the first time.
In addition to increased programming on VERSUS, the Amgen Tour of California
Web site saw a significant increase in traffic during the 2009 race. Total
visitors to the Web site topped 1.3 million in the month of February, compared
to 777,000 in February 2008, and total page impressions for this month exceeded
5.1 million.
“We are enormously satisfied with the race,” said
Andrew Messick, president, AEG Sports, presenter of the race. “We’ve
had some epic racing, beautiful terrain and enormous crowds. The ratings for our
television broadcast were up about 70 percent, we were broadcasting for twice as
many hours and we were broadcast live all over the world. I think people have
gotten a much closer and better perspective of the race and we hope they will
return as fans next year.”
San Diego cancer survivor Gary Miller was honored and celebrated today at the
final Breakaway Mile, a one-mile honorary bicycle ride that crossed the finish
line prior to the professional race conclusion. During the event, Miller was
joined by his support team of family members and close friends, as well as Joe
Miletich, Amgen’s senior vice president of Research & Development, who plays a
crucial role in developing innovate medicines to treat cancer and other serious
illnesses.
“When my husband was diagnosed with prostate cancer it happened at a time
when our health insurance was in transition and we were required to go on COBRA
for several months,” explained Karen Miller, spouse of Breakaway Mile rider Gary
Miller. “My first call was to Patient Advocate Foundation and they were an
immediate source of support and expertise. They guided me through the maze and I
felt a sense of relief and hope.”
Breakaway from Cancer™ nonprofit partners play leading roles in every aspect
of cancer care to help people affected by the disease. The Escondido Breakaway
Mile highlighted the Patient Advocate Foundation, which was established in 1996
as a national 501(c)3 organization with a mission of safeguarding patients with
chronic, life threatening, and/or debilitating illnesses assuring access to
care, maintenance of employment and preservation of their financial stability.
"Breakaway from Cancer is an initiative that captures the essence of every
cancer patient's commitment as they face their fears and race to conquer
cancer,” said Nancy Davenport-Ennis, founder and CEO, Patient Advocate
Foundation. “We are so very honored to be a partner in this event with our
fellow nonprofit colleagues and to join the survivors and their caregivers in
celebrating with professional cyclists the thrill of victory as their ride calls
out the importance of cancer research and survivorship for all patients and
their loved ones in the United States.”
The Breakaway from Cancer initiative is designed to increase awareness of the
important resources available to cancer patients from prevention to education,
and patient care to advocacy and financial support. For the latest information
on Breakaway from Cancer and ways to support those living with the illness,
visit breakawayfromcancer.com.
“Amgen is proud of our sponsorship of the Amgen Tour of California, a
spectacular race that again this year saw the world’s best cyclists battle it
out along California’s beautiful landscape,” said Miletich. In addition to
riding in today’s Breakaway Mile, Miletich also presented the final Amgen Leader
Jersey to 2009 Amgen Tour of California winner Leipheimer.
“As a company dedicated to tapping the power of pioneering science to fight
serious illness, Amgen is passionate about helping people who are battling
cancer, and Breakaway from Cancer is one of the ways that Amgen is fighting
cancer on multiple fronts. The 17,000 staff members at Amgen come to work every
day motivated by the chance to make a dramatic difference in the lives of people
suffering from cancer and other life threatening illnesses.”
- Discuss this race and the sport with other cycling fans from around the
world on the Daily Peloton.com
Forums and Chat Room.
- Sponsor the daily peloton &
advertise your product - contact
us.
- Do you have a passion for cycling and writing about the sport? contact us.
About the Amgen Tour of California
The largest cycling event in America, the Amgen Tour of California is a Tour de
France-style cycling road race, presented by AEG, that challenges the world’s
top professional cycling teams to compete along a demanding course. Building on
last year's third-annual stage race, which attracted 1.6 million spectators, the
2009 Amgen Tour of California will be expanded to cover more than 750 miles over
nine days from February 14-22, 2009.
About Amgen Amgen discovers,
develops, manufactures and delivers innovative human therapeutics. A
biotechnology pioneer since 1980, Amgen was one of the first companies to
realize the new science's promise by bringing safe and effective medicines from
lab, to manufacturing plant, to patient. Amgen therapeutics have changed the
practice of medicine, helping millions of people around the world in the fight
against cancer, kidney disease, rheumatoid arthritis, and other serious
illnesses. With a deep and broad pipeline of potential new medicines, Amgen
remains committed to advancing science to dramatically improve people's lives.
To learn more about Amgen's pioneering science and vital medicines, visit
www.amgen.com. To learn more about Amgen’s Breakaway from Cancer initiative,
visit www.breakawayfromcancer.com.
About AEG AEG is one of the leading
sports and entertainment presenters in the world. AEG, a wholly owned subsidiary
of The Anschutz Company, owns or controls a collection of companies including
facilities such as STAPLES Center, The Home Depot Center, Sprint Center, The O2,
NOKIA Theatre L.A. LIVE and NOKIA Theatre Times Square; sports franchises
including the Los Angeles Kings (NHL), two Major League Soccer franchises, a
Major League Lacrosse team, two hockey franchises operated in Europe, management
of privately held shares of the Los Angeles Lakers, the ING Bay to Breakers foot
race and the Amgen Tour of California cycling road race; AEG LIVE, the
organization’s live-entertainment division, is a collection of companies
dedicated to all aspects of live contemporary music performance, touring and a
variety of programming and multi-media production. For more information, visit
AEG today at www.aegworldwide.com.
For full results, archived footage, team information and more, please visit
the official race Web site at
www.amgentourofcalifornia.com.
|